Jason Luke, MD, FACP
@jasonlukemd
Immunotherapy of Cancer • Melanoma • Phase I Clinical Trials • Lab: @ImmunoTiil • Disclosures: https://t.co/p3vwd3bi9o
ID:3122883010
https://www.tiilab.org/ 28-03-2015 02:37:18
6,8K Tweets
6,1K Followers
564 Following
Follow People
Vote for Robert Ferris, MD, PhD Society for Immunotherapy of Cancer VP now! Election is open & I just placed my vote! As Cancer Center Director, high impact translational researcher/clinical immunotherapist & all around great guy, he is the perfect leader to move the society forward!
sitcancer.org/membership/202…
Very happy to share our lab's work Translational Immuno-Informatics Lab (TIIL) on #organ #heterogeneity #radiomics in #melanoma #immunotherapy #machineLeaning Jason Luke, MD, FACP!!!
Led by brilliant students Alex Tompkins & (prev) Zane Gray PittDeptofMed. Wonderful collab w John M. Kirkwood Hassane Zarour Yana Najjar…
Top advances of the year #Melanoma ! Great work Adnan Khattak on impact of TIL approval, novel strategies targeting PRAME, oncolytic virus as well as neo-/adjuvant strategies such as mRNA individualized neoAg therapy. Quick read to stay UTD!
acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…
Excited to present Society for Immunotherapy of Cancer guidelines for clinical research on intra-tumoral #immunotherapy . This was a collaborative effort from expert stakeholders across academia & industry. Tremendous potential from pre- to advanced cancer for novel agents.
jitc.bmj.com/content/12/4/e…
Super excited to support Robert Ferris, MD, PhD in VP election Society for Immunotherapy of Cancer! Bob is a visionary physician-scientist & executive leader whose career is dedicated to translational #immunology & #immunotherapy . Amazing potential to lead the society. Plz vote for Bob!
contentsharing.net/actions/email_…
Was great to have Society for Immunotherapy of Cancer buddy & superstar immunologist/immunotherapist Marco Ruella here UPMC Hillman Cancer Center PittDeptofMed for grand rounds describing some of his recent work & future vision for #CART ! Congrats Marco on a great body of field-leading work!
Thanks AACR for the profile. Hope all #immunotherapy & #immunology interested folks will join the Cancer Immunology Working Group (CIMM), particularly on LinkedIn for on-going discussions of the field!
#MusicMonday #AACR24 Edition! I had a blast playing with Society for Immunotherapy of Cancer's house band, #TheCheckPoints last night during the AACR annual meeting! Here's our version of 'Sweet Home Chicago.'
Ferran Prat Russell Pachynski Dr. Brad Reinfeld, MD PhD Jason Luke, MD, FACP Jim Allison PhD Padmanee (Pam) Sharma, MD, PhD @Wolchok
Great performance by Checkpoints band at #AACR24 reception, including two rockstar Dragonfly Tx SAB Members, Dr. Patrick Hwu & Jim Allison PhD
The Checkpoints entertaining a huge crowd at #AACR ! All #immunology scientists by day and rock musicians at the conference! Shout out to our Jason Luke, MD, FACP on trumpet! UPMC Pitt Health Sciences UPMC Physician Resources
Had so much fun practicing with The CheckPoints last night getting ready for our Sunday concert at #AACR24 !
Society for Immunotherapy of Cancer Ferran Prat Russell Pachynski Dr. Brad Reinfeld, MD PhD Jason Luke, MD, FACP Jim Allison PhD Padmanee (Pam) Sharma, MD, PhD AACR
Gearing up AACR #AACR24 - annual reception will be rocking w The Checkpoints Society for Immunotherapy of Cancer Everyone in San Diego Sun Apr 7 plz join us in the Manchester Grand Hyatt ballroom! Chops coming into shape w morning ocean sunrise practice sessions! Pass the word to support #CancerResearch
Heads up anyone interested in set up/maintaining adoptive cell transfer program in hem or solid tumors. Great talks Allison Betof Warner, MD, PhD Dr. Syed Haider Advocate Aurora Health w community perspective & Robert Richards on long-term learnings Penn Medicine Join us as I moderate Wed 5 PM ET!
.Jason Luke, MD, FACP discussing rare melanomas and why emerging data around #CXCL8 / #IL8 suggests it could be a good therapeutic target for #AcralMelanoma .
Watch his full session here: ow.ly/68m750QNVcy
Catch up on all #CMC2024 sessions: ow.ly/RVqc50QNVcz
#Melanoma
3 year update for KN716 now online Journal of Clinical Oncology. Foundational data for adjuvant #melanoma emphasizing patients with stage IIB/C dz are at high risk & anti-PD1 is highly effective to prevent recurrence. Next step - biomarker work to optimize patient selection!
ascopubs.org/doi/10.1200/JC…